Drug Patents owned by Dow Pharm
1. List of Altreno drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10653656 | DOW PHARM | Topical pharmaceutical compositions for treating skin conditions |
Aug, 2038
(15 years from now) | |
| US11324710 | DOW PHARM | Topical pharmaceutical compositions for treating skin conditions |
Aug, 2038
(15 years from now) | |
Drugs and Companies using TRETINOIN ingredient
Market Authorisation Date: 23 August, 2018
Treatment: Topical treatment of acne vulgaris in patients 9 years of age and older
Dosage: LOTION;TOPICAL
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic